These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11300866)

  • 21. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
    Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V.
    Sena VL; Srivastava RM; Silva RO; Lima VL
    Farmaco; 2003 Dec; 58(12):1283-8. PubMed ID: 14630240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
    Rizzo M
    IDrugs; 2010 Feb; 13(2):103-11. PubMed ID: 20127562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion.
    Shiomi M; Ito T
    Eur J Pharmacol; 2001 Nov; 431(1):127-31. PubMed ID: 11716851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agents.
    Augelli-Szafran CE; Blankley CJ; Roth BD; Trivedi BK; Bousley RF; Essenburg AD; Hamelehle KL; Krause BR; Stanfield RL
    J Med Chem; 1993 Oct; 36(20):2943-9. PubMed ID: 8411011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile.
    Kim E; Campbell S; Schueller O; Wong E; Cole B; Kuo J; Ellis J; Ferkany J; Sweetnam P
    J Pharmacol Exp Ther; 2011 Jun; 337(3):775-85. PubMed ID: 21406547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New approaches to target microsomal triglyceride transfer protein.
    Hussain MM; Bakillah A
    Curr Opin Lipidol; 2008 Dec; 19(6):572-8. PubMed ID: 18957879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Harris NV; Smith C; Ashton MJ; Bridge AW; Bush RC; Coffee EC; Dron DI; Harper MF; Lythgoe DJ; Newton CG
    J Med Chem; 1992 Nov; 35(23):4384-92. PubMed ID: 1447739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.
    Sulsky R; Robl JA; Biller SA; Harrity TW; Wetterau J; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5067-70. PubMed ID: 15380200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability.
    Gordon DA; Jamil H; Sharp D; Mullaney D; Yao Z; Gregg RE; Wetterau J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7628-32. PubMed ID: 8052632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus fusion inhibitors. Part 4: optimization for oral bioavailability.
    Yu KL; Sin N; Civiello RL; Wang XA; Combrink KD; Gulgeze HB; Venables BL; Wright JJ; Dalterio RA; Zadjura L; Marino A; Dando S; D'Arienzo C; Kadow KF; Cianci CW; Li Z; Clarke J; Genovesi EV; Medina I; Lamb L; Colonno RJ; Yang Z; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):895-901. PubMed ID: 17169560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antihyperlipidemic activity of some novel 4-(substitutedamino)-5-substituted-3-mercapto- (4H)-1,2,4-triazoles.
    Chhabria MT; Suhagia BN; Brahmkshatriya PS; Raval PM
    Arzneimittelforschung; 2011; 61(8):452-7. PubMed ID: 21950149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of microsomal triglyceride transfer protein gene variants (-493G > T, Q95H and H297Q) on plasma lipid levels in healthy middle-aged UK men.
    Talmud PJ; Palmen J; Miller G; Humphries SE
    Ann Hum Genet; 2000 Jul; 64(Pt 4):269-76. PubMed ID: 11415512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation.
    Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X
    Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsomal transfer protein inhibition in humans.
    Cuchel M; Rader DJ
    Curr Opin Lipidol; 2013 Jun; 24(3):246-50. PubMed ID: 23594709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.